NCT05816265View on ClinicalTrials.gov

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Heart FailureIron-deficiency
Interventions
DRUG

IV Iron Infusion Group

Subjects will receive IV Iron Infusion. Dosage of iron will be at discretion of physicians

Trial Locations (1)

85006

Banner - University Medical Center, Phoenix campus, Phoenix

Sponsors

Collaborators (1)

American Regent, Inc.
All Listed Sponsors
collaborator

American Regent, Inc.

INDUSTRY

lead

Radha Gopalan

OTHER

NCT05816265 - Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure | Biotech Hunter | Biotech Hunter